Emerging Concepts in Treating Triple-Negative Breast Cancer

EP. 1: Classification of Triple Negative Breast Cancer

February 15th 2018

EP. 2: Histologic Subtyping in TNBC

February 15th 2018

EP. 3: Germline BRCA Mutations in TNBC

February 15th 2018

EP. 4: NCCN Guideline Changes for BRCA Testing in TNBC

February 15th 2018

EP. 5: Sequencing in BRCA-Positive TNBC Patients

February 15th 2018

EP. 6: Combining PARP Inhibitors + Checkpoint Inhibitors in TNBC

February 15th 2018

EP. 7: Neoadjuvant Therapy in TNBC

February 15th 2018

EP. 8: Anthracycline-Based Regimens: Perioperative Setting for TNBC

February 15th 2018

EP. 9: No pCR in Patients After Neoadjuvant Chemotherapy in TNBC

February 15th 2018

EP. 10: Paclitaxel vs Nab-Paclitaxel in Metastatic TNBC

February 15th 2018

EP. 11: Antibody-Drug Conjugates in Treating TNBC

February 15th 2018

EP. 12: Checkpoint Inhibitor Monotherapy for TNBC

February 15th 2018

EP. 13: Combination Therapy for TNBC: Checkpoint Inhibitor + Chemotherapy

February 15th 2018

EP. 14: Role of the Androgen Receptor in TNBC

February 15th 2018

EP. 15: Other Promising Targets in TNBC

February 15th 2018